April 21, 2023
Shardul Amarchand Mangaldas & Co. successfully represented Berhyanda Limited (a company controlled by funds managed by Advent International Corporation) (Acquirer) on its acquisition of majority shareholding of Suven Pharmaceuticals Limited (Suven / Target).
The transaction has been unconditionally approved by the Competition Commission of India on 20 April, 2023. The transaction is one of the largest deals in the pharmaceutical sector in India.
The Competition Team was led by Aparna Mehra, Partner; Krithika Ramesh, Senior Associate; Ritika Sood, Senior Associate; Kshitij Sharma, Associate; Ishaan Chakrabarti, Associate; Karan Arora, Associate and Sarthak Mishra, Associate.
The Transaction Team was led by Iqbal Khan, Partner and Ambarish, Partner.
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
Click here for important public notice from the Firm.